Sustained Neuromuscular Blockade after Vecuronium Use in a Premature Infant

Area of Science:

• Pediatric Critical Care Medicine
• Neonatal Intensive Care
• Pharmacology

Background:

• Neuromuscular blocking agents (NMBAs) are frequently used in critically ill children.
• Limited safety data and no US guidelines exist for NMBA use in pediatric and neonatal populations.
• NMBAs are essential for managing respiratory failure and facilitating mechanical ventilation in intensive care settings.

Observation:

• A case of prolonged neuromuscular blockade is presented in a premature infant.
• The infant received a neuromuscular blocking agent concurrently with aminoglycosides and steroids.
• The infant also experienced renal failure, complicating the clinical picture.

Findings:

• Concurrent administration of NMBAs with aminoglycosides and steroids can potentiate neuromuscular blockade.
• Renal failure exacerbates the risk and duration of neuromuscular blockade.
• Prolonged NMBA use in preterm infants requires careful consideration of drug interactions and organ function.

Implications:

• Avoid prolonged NMBA use in preterm infants whenever possible.
• If NMBA use is necessary, restrict it to the shortest effective duration and lowest effective dose.
• Avoid concurrent NMBA administration with aminoglycosides and steroids, particularly in neonates with renal impairment.